All Stories

  1. Comparative Effectiveness And Cost-Effectiveness Analyses Frequently Agree On Value

    Article • Health Affairs, May 2015, Health Affairs

    Professor Daniel Polsky, Dr Eleanor M Perfetto

  2. Iqwig Early Benefit Assessments Of Type 2 Diabetes Therapies

    Article • Value in Health, May 2015, Elsevier

    Dr Eleanor M Perfetto

  3. Measuring function in cognitive impairment: a suggested taxonomy for characterizing assessment instruments

    Article • Value in Health, May 2015, Elsevier

    Dr Eleanor M Perfetto

  4. Improvements in self-reported real-world decision-making ability after completion of a comparative effectiveness research continuing Education Certificate

    Article • Value in Health, May 2015, Elsevier

    Dr Eleanor M Perfetto

  5. Communication About Results Of Comparative Effectiveness Studies: A Pharmaceutical Industry View

    Article • Health Affairs, October 2012, Health Affairs

    Dr Eleanor M Perfetto

  6. PMS57 EVIDENCE APPRAISAL FOR THE TREATMENT OF FIBROMYALGIA: COMPENDIA, GUIDELINES, AND A REVIEW OF CLINICAL TRIALS

    Article • Value in Health, May 2010, Elsevier

    Dr Eleanor M Perfetto

  7. Applying item response theory to enhance health outcomes assessment

    Article • Quality of Life Research, May 2007, Springer Science + Business Media

    Dr Eleanor M Perfetto, Professor Ron D. Hays

  8. PNL12 COST-EFFECTIVENESS OF ELETRIPTAN VERSUS SUMATRIPTAN: RESULTS FROM A RANDOMIZED, CONTROLLED TRIAL

    Article • Value in Health, May 2006, Elsevier

    Dr Eleanor M Perfetto

  9. An Economic Evaluation of Triptan Products for Migraine

    Article • Value in Health, November 2005, Elsevier

    Dr Eleanor M Perfetto

  10. PIN24 ACUTE SINUSITIS OUTCOMES AND CHARGES: A COMPARISON OF TWO FLUOROQUINOLONES

    Article • Value in Health, May 2005, Elsevier

    Dr Eleanor M Perfetto

  11. PNL11 AN ECONOMIC EVALUATION OFTRIPTAN PRODUCTS FOR MIGRAINE

    Article • Value in Health, May 2005, Elsevier

    Dr Eleanor M Perfetto

  12. PNL12 TRIPTANS FOR MIGRAINE THERAPY: A COMPARISON BASED ON NUMBER NEEDED TO TREAT AND DOSES NEEDED TO TREAT

    Article • Value in Health, May 2005, Elsevier

    Dr Eleanor M Perfetto

  13. PUK3 AN ECONOMIC MODEL OF OVERACTIVE BLADDER TREATMENT PERSISTENCE:TOLTERODINE ER COMPARED TO OXYBUTYNIN ER

    Article • Value in Health, May 2005, Elsevier

    Dr Eleanor M Perfetto

  14. PIN25 CHRONIC RHINOSINUSITIS TREATMENT: A COMPARISON OF MOXIFLOXACIN AND LEVOFLOXACIN TREATMENT DURATION, OUTCOMES.AND CHARGES

    Article • Value in Health, May 2005, Elsevier

    Dr Eleanor M Perfetto

  15. PRP17 ESTIMATING HOSPITAL BURDEN DUE TO PNEUMONIA, ASPIRATION, AND ACUTE LUNG FAILURE: DATA FROM THE NATIONAL HOSPITAL DISCHARGE SURVEY (NHDS)

    Article • Value in Health, November 2003, Elsevier

    Dr Eleanor M Perfetto